Table 1.

Patient and disease characteristics

Characteristic	Patients (N = 15)
Median age, y (range)	65 (46 – 76)
ECOG performance status, n (%)
0	7 (46.7)
1	8 (53.3)
Race/Ethnicity, n (%)
White, Hispanic	3 (20.0)
White, non-Hispanic	12 (80.0)
Primary site, n (%)
Ovarian	10 (66.7)
Fallopian tube	3 (20.0)
Peritoneal	2 (13.3)
FIGO stage, n (%)
IIIC	15 (100.0)
Cell type, n (%)
Serous	13 (86.7)
Mixed epithelial	1 (6.7)
Other	1 (6.7)
Tumor grade, n (%)
2	1 (6.7)
3	14 (93.3)
Primary site, n (%)
Ovarian	10 (66.7)
Fallopian tube	3 (20.0)
Peritoneal	2 (13.3)
Residual disease, n (%)
0	5 (33.3)
<1cm	10 (66.7)
Neoadjuvant chemotherapy, n (%)
Yes	3 (20.0)
No	12 (80.0)

Abbreviation: ECOG, Eastern Cooperative Oncology Group

Abbreviation: FIGO, International Federation of Gynecology and Obstetrics